CRWD vs MRVL: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and Marvell Technology, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-24.
CrowdStrike Holdings, Inc. Β· Technology
$436.32
+34.6% upside to fair value
Grade B
VS
Marvell Technology, Inc. Β· Technology
$133.37
+23.0% upside to fair value
High Conviction Grade B
QuantHub Verdict
CRWD has more upside to fair value (+34.6%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD MRVL
Current Price $436.32 $133.37
Fair Value Estimate $587.16 $164.02
Upside to Fair Value +34.6% +23.0%
Market Cap $110.7B $116.6B
Forward P/E -601.6x 42.4x
EV / EBITDA 951.5x β€”
Price / Sales 23.0x 14.2x
Price / FCF 89.3x 83.7x
Revenue Growth YoY +23.3% +7.0%
Gross Margin 74.9% 50.1%
Operating Margin -5.4% 16.3%
Return on Equity -4.7% 19.4%
Dividend Yield 0% β€”
FCF Yield 1.12% 1.2%
Analyst Consensus Buy Strong Buy
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-based endpoint protection and threat intelligence, with a dominant subscription revenue model accounting for over 95% of total revenue. The business quality is medium due to strong revenue growth of 23.3% in the most recent quarter and a robust earnings growth of 141.9% in the same period, supported by a high gros…
MRVL β€” Marvell Technology, Inc.
Marvell Technology designs semiconductors for data infrastructure, including storage, networking, connectivity for AI, cloud, 5G, and automotive; the business excels with a dominant Data Center segment driving 42% FY2026 revenue growth to $8.2B amid AI demand, strong leadership under long-tenured CEO Matt Murphy, and robust 50% gross margins, though offset by earnings decline and non-Data Center …
Accumulation Zones
Metric CRWD MRVL
Zone Low $440.37 $123.02
Zone High $499.09 $139.42
In Buy Zone? Yes Yes
← CRWD Research    MRVL Research β†’    All Research